Skip to main content

PMV Pharmaceuticals, Inc.

PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001699382

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q3 2026, worth $94.4M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in PMV Pharmaceuticals, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
64
+1 vs. Q2 2026
Shares held
56.5M
+22.3M (+64.9%) vs. Q2 2026
Total value
$94.4M
+$48.5M (+105.5%) vs. Q2 2026
New holders
9
22 more added
Sold out
8
12 more reduced

1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 64 institutions
Q1 2021: 81 institutionsQ2 2021: 86 institutionsQ3 2021: 92 institutionsQ4 2021: 105 institutionsQ1 2022: 99 institutionsQ2 2022: 105 institutionsQ3 2022: 120 institutionsQ4 2022: 115 institutionsQ1 2023: 113 institutionsQ2 2023: 106 institutionsQ3 2023: 104 institutionsQ4 2023: 98 institutionsQ1 2024: 99 institutionsQ2 2024: 93 institutionsQ3 2024: 74 institutionsQ4 2024: 70 institutionsQ1 2025: 55 institutionsQ2 2025: 54 institutionsQ3 2025: 64 institutionsQ4 2025: 65 institutionsQ1 2026: 69 institutionsQ2 2026: 64 institutionsQ3 2026: 64 institutions
Value heldQ3 2026: $94.4M
Q1 2021: $1.31BQ2 2021: $1.44BQ3 2021: $1.31BQ4 2021: $1.10BQ1 2022: $1.15BQ2 2022: $870.9MQ3 2022: $692.3MQ4 2022: $474.5MQ1 2023: $245.7MQ2 2023: $324.0MQ3 2023: $333.0MQ4 2023: $144.0MQ1 2024: $72.7MQ2 2024: $65.6MQ3 2024: $58.2MQ4 2024: $58.8MQ1 2025: $40.7MQ2 2025: $36.8MQ3 2025: $52.5MQ4 2025: $46.8MQ1 2026: $45.8MQ2 2026: $45.9MQ3 2026: $94.4M
Institutions holding PMVP and their total value by quarter
QuarterHoldersValue
Q3 202664$94.4M
Q2 202664$45.9M
Q1 202669$45.8M
Q4 202565$46.8M
Q3 202564$52.5M
Q2 202554$36.8M
Q1 202555$40.7M
Q4 202470$58.8M
Q3 202474$58.2M
Q2 202493$65.6M
Q1 202499$72.7M
Q4 202398$144.0M
Q3 2023104$333.0M
Q2 2023106$324.0M
Q1 2023113$245.7M
Q4 2022115$474.5M
Q3 2022120$692.3M
Q2 2022105$870.9M
Q1 202299$1.15B
Q4 2021105$1.10B
Q3 202192$1.31B
Q2 202186$1.44B
Q1 202181$1.31B

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q2 2026.

Institutions holding PMVP in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BML Capital Management, LLC7,330,000$12.2M6.57%+2,000,000+37.5%Added
Tang Capital Management LLC7,285,085$12.2M0.56%+3,040,000+71.6%Added
Samsara BioCapital, LLC7,240,000$12.1M1.15%+7,240,000New
Sio Capital Management, LLC3,634,137$6.07M1.29%+1,000,000+38.0%Added
Vanguard Capital Management LLC3,083,667$5.15M0.00%+1,071,647+53.3%Added
ADAR1 Capital Management, LLC2,700,349$4.51M0.19%+2,499,341+1,243.4%Added
Euclidean Capital LLC2,627,643$4.39M1.36%00.0%Unchanged
Two Sigma Investments, LP2,429,330$4.06M0.00%+475,194+24.3%Added
Adage Capital Partners GP, L.L.C.2,360,000$3.94M0.01%00.0%Unchanged
Acadian Asset Management LLC2,285,479$3.81M0.00%+69,585+3.1%Added
Boxer Capital Management, LLC2,050,000$3.42M0.30%+2,050,000New
Eversept Partners, LP1,964,624$3.28M0.19%+73,720+3.9%Added
Affinity Asset Advisors, LLC1,750,000$2.92M0.17%+1,750,000New
ArrowMark Colorado Holdings LLC1,694,798$2.83M0.13%−264,781−13.5%Reduced
Millennium Management LLC1,461,926$2.44M0.00%+1,461,926New
BlackRock, Inc.916,518$1.53M0.00%−3,300−0.4%Reduced
BIT Capital GmbH714,407$1.19M0.04%+306,852+75.3%Added
Geode Capital Management, LLC500,327$836.3K0.00%+27,169+5.7%Added
Aldebaran Capital, LLC489,540$817.5K0.59%+22,108+4.7%Added
Walleye Capital LLC487,141$813.5K0.00%+151,447+45.1%Added
Bridgeway Capital Management, LLC427,528$714.0K0.01%−1,325−0.3%Reduced
Assenagon Asset Management S.A.328,744$549.0K0.00%−1,259−0.4%Reduced
Vanguard Fiduciary Trust Co301,866$504.1K0.00%+47,091+18.5%Added
Citadel Advisors LLC268,338$448.1K0.00%+221,030+467.2%Added
Bank of America Corp265,898$444.1K0.00%+25,788+10.7%Added
Marshall Wace, LLP220,760$368.7K0.00%−100,850−31.4%Reduced
State Street Corp183,178$305.9K0.00%00.0%Unchanged
RBF Capital, LLC162,200$270.9K0.01%00.0%Unchanged
Goldman Sachs Group Inc156,869$262.0K0.00%+19,875+14.5%Added
MAI Capital Management133,122$222.3K0.00%00.0%Unchanged
Susquehanna International Group, LLP130,673$218.2K0.00%+93,142+248.2%Added
Connor, Clark & Lunn Investment Management Ltd.110,086$183.8K0.00%+77,626+239.1%Added
HRT Financial LP103,270$172.0K0.00%+52,760+104.5%Added
Rangeley Capital, LLC99,240$165.7K0.23%00.0%Unchanged
Northern Trust Corp93,047$155.4K0.00%00.0%Unchanged
Ikarian Capital, LLC89,136$148.9K0.03%00.0%Unchanged
Empowered Funds, LLC75,575$126.2K0.00%+75,575New
Accurate Wealth Management, LLC50,000$70.5K0.01%00.0%Unchanged
Jacobs Levy Equity Management, Inc35,817$59.8K0.00%−34,687−49.2%Reduced
HSBC Holdings PLC30,891$49.1K0.00%00.0%Unchanged
Gsa Capital Partners LLP27,382$46.0K0.00%+27,382New
Barclays PLC27,536$46.0K0.00%−225−0.8%Reduced
Boothbay Fund Management, LLC27,126$45.3K0.00%00.0%Unchanged
Quadrature Capital Ltd23,756$39.7K0.00%−38,314−61.7%Reduced
Vanguard Global Advisers, LLC21,559$36.0K0.00%00.0%Unchanged
Point72 Asset Management, L.P.18,819$31.4K0.00%+18,819New
Pathstone Holdings, LLC17,487$29.2K0.00%00.0%Unchanged
CI Private Wealth, LLC15,000$25.1K0.00%00.0%Unchanged
Jane Street Group, LLC14,245$23.8K0.00%−25,962−64.6%Reduced
Morgan Stanley13,719$22.9K0.00%−27,965−67.1%Reduced
Sand Hill Global Advisors, LLC12,539$20.9K0.00%00.0%Unchanged
Independent Advisor Alliance12,500$20.9K0.00%00.0%Unchanged
Claret Asset Management Corp10,703$18.0K0.00%+10,703New
Deerfield Management Company, L.P. (Series C)8,790$14.7K0.00%00.0%Unchanged
Silver Grove Financial Group, Inc.5,082$8.49K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.2,205$3.68K0.00%−65,733−96.8%Reduced
Russell Investments Group, Ltd.2,001$3.34K0.00%+2,001New
Tower Research Capital LLC (TRC)1,000$1.67K0.00%−64−6.0%Reduced
Jones Financial Companies LLLP1,000$1.33K0.00%00.0%Unchanged
JPMorgan Chase & Co614$8780.00%+400+186.9%Added
BNP Paribas Arbitrage, SA518$8650.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd375$6260.00%+357+1,983.3%Added
UBS Group AG361$6030.00%00.0%Unchanged
Group One Trading, L.P.155$2590.00%+65+72.2%Added
Stonepine Capital Management, LLC0$00.00%−536,086−100.0%Sold out
Verdad Advisers, LP0$00.00%−362,361−100.0%Sold out
Seven Fleet Capital Management LP0$00.00%−53,569−100.0%Sold out
Algert Global LLC0$00.00%−39,853−100.0%Sold out
Cooper/Haims Advisors, LLC0$00.00%−39,021−100.0%Sold out
Squarepoint Ops LLC0$00.00%−31,833−100.0%Sold out
Citigroup Inc0$00.00%−19,296−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−10,200−100.0%Sold out
Royal Bank of Canada––––Not filed